New Non-Invasive Tests Show Promise for Diagnosing Liver Disease, Potentially Reducing Need for Biopsy

Two major international studies, including one led by researchers from the Radcliffe Department of Medicine and published in The Lancet and Nature Medicine, have provided new evidence on the accuracy of non-invasive tests for diagnosing and measuring the severity of metabolic dysfunction-associated steatotic liver disease (MASLD) and its more severe form, MASH. The findings from these studies, part of the LITMUS programme, could significantly reduce reliance on liver biopsies for diagnosis.